Prostate Cancer Metastatic: 1673 Clinical Trials, Page 166 of 168

Hide Studies Not Open or Pending

1658

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors

Condition(s):ER+ Breast Cancer; Ovarian Cancer; Cervical Squamous Cell Carcinoma; Pancreatic Adenocarcinoma; Endometrial Cancer; Renal Cell Carcinoma; Urothelial Cancer; Head and Neck Squamous Cell Carcinoma; Mesothelioma; Melanoma; Hepatocellular Carcinoma; Prostate Cancer; NSCLC; HER2-negative Breast Cancer; Triple Negative Breast Cancer; Bladder Cancer; Colorectal Cancer Metastatic; GastroEsophageal Cancer; NSCL2 Gene MutationLast Updated:October 26, 2020Recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.